Rachel Ellingson - Net Worth and Insider Trading

Rachel Ellingson Net Worth

The estimated net worth of Rachel Ellingson is at least $330,392 dollars as of 2024-11-13. Rachel Ellingson is the VP, Global Communications of St Jude Medical Inc and owns about 4,088 shares of St Jude Medical Inc (STJ) stock worth over $330,392. Details can be seen in Rachel Ellingson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rachel Ellingson has not made any transactions after 2015-04-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rachel Ellingson

To

Rachel Ellingson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rachel Ellingson owns 2 companies in total, including BioLife Solutions Inc (BLFS) , and Zimmer Biomet Holdings Inc (ZBH) .

Click here to see the complete history of Rachel Ellingson’s form 4 insider trades.

Insider Ownership Summary of Rachel Ellingson

Ticker Comapny Transaction Date Type of Owner
BLFS BioLife Solutions Inc 2021-04-01 director
ZBH Zimmer Biomet Holdings Inc 2021-01-04 SVP & CSO

Rachel Ellingson Latest Holdings Summary

Rachel Ellingson currently owns a total of 1 stock. Rachel Ellingson owns 4,088 shares of St Jude Medical Inc (STJ) as of April 24, 2015, with a value of $330,392.

Latest Holdings of Rachel Ellingson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
STJ St Jude Medical Inc 2015-04-24 4,088 80.82 330,392

Holding Weightings of Rachel Ellingson


Rachel Ellingson Form 4 Trading Tracker

According to the SEC Form 4 filings, Rachel Ellingson has made a total of 0 transactions in St Jude Medical Inc (STJ) over the past 5 years. The most-recent trade in St Jude Medical Inc is the sale of 4,416 shares on April 24, 2015, which brought Rachel Ellingson around $326,784.

Insider Trading History of Rachel Ellingson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rachel Ellingson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rachel Ellingson Ownership Network

Ownership Network List of Rachel Ellingson

No Data

Ownership Network Relation of Rachel Ellingson

Insider Network Chart

Rachel Ellingson Owned Company Details

What does BioLife Solutions Inc do?

Who are the key executives at BioLife Solutions Inc?

Rachel Ellingson is the director of BioLife Solutions Inc. Other key executives at BioLife Solutions Inc include Chief Tech. Officer & Sr. VP Aby J. Mathew , Vice President & Marketing Todd Berard , and Vice President of Operations Karen A. Foster .

BioLife Solutions Inc (BLFS) Insider Trades Summary

Over the past 18 months, Rachel Ellingson made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 115,454 shares made by Aby J. Mathew , a net sale of 44,009 shares made by Todd Berard , and a net sale of 18,299 shares made by Troy Wichterman .

In summary, during the past 3 months, insiders sold 49,769 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 49,769 shares. During the past 18 months, 351,260 shares of BioLife Solutions Inc (BLFS) were sold and 1,135,630 shares were bought by its insiders, resulting in a net purchase of 784,370 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioLife Solutions Inc Insider Transactions

No Available Data

Rachel Ellingson Mailing Address

Above is the net worth, insider trading, and ownership report for Rachel Ellingson. You might contact Rachel Ellingson via mailing address: 345 E Main Street, Warsaw K7 46580.